Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.273NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.13 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.358NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.60NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.159NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.510NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.91NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.227NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.555NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.513NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HN.4.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XACNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.6.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EJ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.77NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.423NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.550NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.261NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EP.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.15.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCBNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.15.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XSNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.4.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.74NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.6.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.238NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.68NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BR.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used